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Myocardial Protection During Surgical Coronary Reperfusion
ELIOT R. ROSENKRANZ, MD, GERALD D. BUCKBERG, MD
Los Angeles, California
Reperfusion injury in the surgical setting is defined as
those metabolic, functional and structural consequences
of restoring coronary flow (that is, aortic unclamping
and revascularization) that can be avoided or reversed
by modification of the conditions of reperfusion by the
operating surgeon. The potential for reperfusion damage
exists during cardiac surgery because temporary myo-
cardial ischemia (that is, aortic clamping) is needed to
produce a quiet, bloodless surgical field. Cold cardio-
plegic techniques have decreased the risks of ischemic
myocardial damage during aortic clamping, but reper-
fusion damage can still occur when there is poor car-
dioplegic distribution (that is, coronary artery disease)
We define reperfusion injury in the surgical setting as those
metabolic, functional and structural consequences of re-
storing coronary flow (that is, aortic unclamping and revas-
cularization) that can be avoided or reversed by modification
of the conditions of reperfusion by the operating surgeon.
This damage occurs only when there has been inadequate
myocardial protection during the preceding ischemic period.
The development of cold cardioplegic techniques has de-
creased ischemic damage during aortic clamping provided
that an appropriately designed cardioplegic solution is de-
livered in adequate amounts to all myocardial segments and
replenished periodically (1). Significant ischemic events be-
fore aortic clamping will, however, deplete the heart of its
energy reserves and thereby limit the effectiveness of car-
dioplegic protection.
The potential for reperfusion damage is always present
during cardiac surgery (elective or emergency, with and
without coronary artery disease) because temporary aortic
clamping is needed to produce the quiet bloodless field
necessary for ideal operating conditions. Our studies over
the past 6 years (2-16) suggest that much of reperfusion
damage may be avoided or reversed by adjusting the tem-
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or in hearts that have suffered ischemic damage before
extracorporeal circulation is started (such as extending
myocardial infarction, cardiogenic shock and the like).
The surgical setting affords the ideal opportunity for
reperfusate modification because the components and
conditions of the reperfusate are in the surgeon's control.
This study reviews present understanding of the nature
of reperfusion damage in the surgical setting and sum-
marizes studies over the past 6 years which suggest that
much of reperfusion damage can be avoided or reversed
by adjusting the temperature, pressure and composition
of reperfusate blood.
perature, pressure and composition of reperfusate blood.
These early observations (17-19) of the benefits of surgical
reperfusate modification led to the subsequent development
of our current technique of blood cardioplegia to prevent
ischemic damage.
This report will 1) summarize our current understanding
of the nature of reperfusion damage in the surgical setting
and define the types of patients and operative conditions
most vulnerable to such damage; 2) list the principles evolv-
ing from our reperfusion research that we use clinically to
modify this damage; and 3) review our data showing how
such damage can be avoided and reversed.
Nature of Surgical Ischemic and
Reperfusion Injury
Ischemic Injury
Myocardial ischemia (with or without hypothermia) re-
sults in the heart's reversion from aerobic oxidation of sub-
strate (glucose, free fatty acids and lactate) by the Krebs
cycle and oxidative phosphorylation (yielding 36 mol ad-
enosine triphosphate [ATP]/mol glucose) to anaerobic gly-
colysis (yielding only 2 mol ATP/mol glucose) for energy
production. Myocardial oxygen reserves are rapidly de-
pleted in the absence of coronary flow. and energy demands
cannot be met with anaerobic glycolysis alone (20). The
accumulation of the end products of anaerobic glycolysis
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(dihydronicotinamide adenine dinucleotide [NADH], hy-
drogen ion [H +] and lactate) results in cellular acidosis that
inhibits further anaerobic glycolysis (21-23), Simulta-
neously, cardiac amino acid metabolism is altered so that
tissue levels of important amino acid (such as glutamate and
aspartate) precursors of Krebs cycle intermediates are de-
creased. Loss of these amino acids deprives the heart of an
alternate source of ATP production during ischemia and may
limit resumption of oxidative metabolism during reperfusion
(24-35),
Limitation of anaerobic AT? production leads to inhi-
bition of cellular processes regulating cell volume (sodium-
potassium ATPase pump) and increases cell membrane
permeability to extracellular calcium, causing intracellular
calcium content to increase. Impairment of ATP-dependent
calcium pumping into the sarcoplasmic reticulum reduces
calcium ion (Ca2 +) sequestration and results in subcellular
organelle injury (because of deposition of calcium in mi-
tochondrial crista spaces) and ultimate myofibrillar con-
tracture (36,37),
The cascade of injury progresses as the duration of isch-
emia and energy depletion increases. Disagreement exists
as to the exact point where irreversibility occurs. Jennings
and Ganote (36,37) suggest that the working heart with
regional ischemia is damaged irreversibly after 40 minutes;
massive structural changes occur after reperfusion with un-
modified blood. Ischemic damage of a working heart with
coronary ligation is probably more extensive than in the
surgical setting of global ischemia of a bypassed heart with
hypothermia and cardioplegia. However, many ultrastruc-
tural changes after unmodified reperfusion (such as release
of coronary ligature and thrombolysis) were not present
during coronary flow interruption (37), This observation
implies that modification of the conditions of reperfusion,
as is possible during cardiac surgery, may avoid the changes
we describe later.
Reperfusion Injury
Aortic unclamping without reperfusate modification is
followed by depression of left ventricular metabolic and
mechanical function even after short ischemic intervals
(9,38,39). It is unsettled whether this represents an un-
masking of irreversible ischemically induced damage (36,37)
or an active process of continued reperfusion injury,
Metabolically, reperfusion damage is characterized by
the inability of the heart to take up and utilize oxygen nor-
mally. Kane (40) and Wood (41) and their co-workers found
that mitochondrial oxygen uptake remains reduced after re-
perfusion, and identified a defect in electron transport in the
respiratory chain. These abnormalities may be due to struc-
tural changes after reperfusion or functional alterations of
the pathways of oxidative metabolism. Abnormalities in
mitochondrial oxygen metabolism may also cause genera-
tion of cytotoxic oxygen metabolites which produce further
profound changes in membrane lipids which alter mor-
phology and function (42,43).
Previously, the metabolic defects caused by ischemia and
reperfusion have been characterized by the degree of ATP
depression (44). We believe these reduced ATP levels reflect
both a loss of adenine nucleotide precursors (45-47) and,
more importantly, an abnormality in the rate of ATP pro-
duction due to a defect in mitochondrial oxidative metab-
olism (40).
Controversy exists over the specific cause of mitochon-
drial dysfunction. Jennings (37), Naylor (48) and Peng (49)
and their co-workers reported abnormal mitochondrial cal-
cium metabolism after reperfusion; the rapid calcium influx
with inadequate sequestration results in dense mitochondrial
calcium deposits seen by electron microscopy. This lowers
ATP stores and production at a time when the heart needs
to replenish energy deficits, repair damage incurred during
ischemia and produce energy for ongoing circulatory func-
tion. Damage to the ATP-dependent cell volume regulatory
apparatus results in edema formation and further deterio-
ration of subcellular anatomy. Such edema may change
intracellularionic gradients causing arrhythmias, impair blood
flow during reperfusion and decrease postischemic
compliance.
Vulnerability to Reperfusion Damage
The potential for intraoperative reperfusion damage is
decreased substantially by cold cardioplegic techniques that
lower myocardial energy demands and retard energy deple-
tion during aortic clamping (17,50-52). The tolerance to a
standard ischemic insult is decreased when energy levels
are low before aortic clamping (53). Left ventricular sub-
endocardial muscle ATP levels may be decreased in patients
with cardiac hypertrophy (54,55) as well as in those with
extensive coronary artery disease (56). Similar depletion of
energy levels before aortic clamping may occur in patients
with advanced heart disease (New York Heart Association,
class IV) or those who sustain major supply-demand
discrepancies, cardiogenic shock or cardiac arrest before
cardioplegia can be initiated (57,58). In addition, unsatis-
factory myocardial protection during aortic clamping, such
as poor distribution of cardioplegic solution or inadequate
replenishment, will deplete myocardial reserves.
Interventions to Avoid or Reverse
Reperfusion Damage
The remainder of this review will summarize our studies
on reperfusate modification in hearts subjected to intentional
ischemia before undergoing reperfusate modification.
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CPD = citrate-phosphate-dextrose; Het = hematocrit; KCl = potassium eh1onde.
Table 1. Principle~ of Reperfusate Modification
{K+
Low [Ca++]
pH 7.8
Reperfusote
I
[K+] Low [Ca++] pH 78
100 -------------------------
Unmodified
*25cc EDV
and myocardial relaxation) (13). Similar prevention of cal-
cium influx can be accomplished pharmacologically with
nifedipine (48,68), verapamil (48,69) and diltiazem (70).
These drugs do, however, have a prolonged half life so that
persistent myocardial depression caused by continued drug
action after bypass may limit their usefulness. The proper
antidote for these calcium antagonists, once developed, will
likely lead to their replacing citrate-phosphate-dextrose which
has a very transient effect.
Alkalosis. We reasoned that modifying reperfusate pH
would be beneficial because metabolic processes are pH-
dependent and would function best if pH was appropriate
for temperature and the intracellular acidosis of ischemia
was reversed immediately (71,72). Additionally, persistent
acidosis would impair calcium ionic flux (73,74). Our bioas-
say data showed that pH 7.8 provided 90% recovery of left
ventricular contractility (3,13). We selected tromethamine
(THAM) buffer because it enters the cell readily, functions
both intracellularly and extracellularly and may be more
effective than ionic buffers (such as sodium bicarbonate) in
ischemic tissue (75-77). Other buffers (78) may be equally
useful, but we did not test them. THAM probably did not
improve postischemic performance by direct inotropic and
alkalotic effects because pH was 7.4 when function and
metabolism were assessed, our dose was less than that re-
ported to increase contractility (79) and no inotropic effect
occurred in pilot studies where pH 7.4 THAM-containing
blood perfusion was carried out (13).
Hypocalcemia and alkalosis. We anticipated that com-
bining hypocalcemia and alkalotic reperfusion would have
additional benefits because each decreased reperfusion dam-
age markedly. Hearts reperfused with alkalotic hypocal-
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Figure 1. Recovery of left ventricular performance after 60 min-
utesof topical hypothermic ischemic arrest. Values are expressed
as percent recovery of first derivative of left ventricular pressure
(+dP/dt). Note: 1)poorest recovery with unmodified reperfusion;
2)better,butincomplete, recovery withmodification of reperfusate
potassium (K+), calcium (Ca' ") and pH; and 3) complete re-
covery with hypocalcemic, alkalotic blood cardioplegic reperfu-
sion. EDV = left ventricular end-diastolic volume.
Method
Blood (Hct 20 to 30%)
Cardioplegia (KCI)
Normothermia (37°C)
Chelation (CPD)
Buffer (THAM)
Hyperosmolarity (360 mOsm)
Low pressure (50 mm Hg)
Glutamate (26 mM)
Provide oxygen
Lower energy demands
Optimize metabolic rate
Reduce calcium influx
Reverse acidosis
Avoid edema
Principle
Replenish substrates
Avoidance of Reperfusion Damage
To study reperfusion injury, we used a model of the
standard ischemic insult produced by 1 hour of topical hy-
pothermic ischemic arrest, because this technique has been
used clinically (59) and has been shown experimentally to
produce acute (60) and chronic (61) myocardial damage.
We tested the hypothesis that the metabolic and functional
consequences of such an insult could be avoided almost
completely by modifying the temperature, pressure and ionic
composition of reperfusate blood during the early phases of
reoxygenation (that is, the first 5 minutes).
The principles addressed in this aspect ofour study (Ta-
ble 1) include: 1) reducing ionic calcium available to enter
the cell by chelation with citrate-phosphate-dextrose (CPD)
(2,13), 2) making reperfusate pH alkalotic to counteract
tissue acidosis and optimize enzymatic and metabolic func-
tion during recovery (62,63), 3) lowering energy demands
by maintaining temporary cardioplegia during reperfusion
to allow the limited oxygen utilization ability to be chan-
neled toward reparative processes (4,13), 4) inducing hy-
perosmolarity and decreasing perfusion pressure (50 mm
Hg) to reverse and minimize reperfusion edema (64-66),
and 5) warming the reperfusate to optimize the rate of met-
abolic recovery (10).
When measured 30 minutes later (at a time when bypass
would be discontinued in the clinical setting), each inter-
vention improved, but did not restore postischemic metab-
olism and function to normal. A combination of these in-
terventions, however, resulted in a level of cardiac
metabolism, compliance and performance that was indis-
tinguishable from control values (Fig. I).
Hypocalcemia. Calcium deposition in mitochondria and
myofibrillar contraction bands are consistent features of re-
perfusion injury (37,67). We chelated reperfusate ionic cal-
cium with CPD to decrease cellular calcium influx, hoping
the Ca2 + metabolism would improve with reoxygenation.
Our bioassay data suggested the best initial reperfusate Ca2 +
to be 1.0 mEq/liter, because this level of temporary hy-
pocalcemia restored 82% contractility ( + dP/dt) and allowed
90% recovery of negative first derivative of left ventricular
pressure (- dP/dt) (a barometer of calcium sequestration
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Figure 2. Postischemic left ventricular performance assessed by
isovolumetric function curves and expressed as percent control at
25 cc left ventricular end-diastolic volume (EDV). Note: I) marked
depression in hearts receiving an unmodified reperfusate; 2) better
recovery in hearts receiving either a low calcium or pH 7.8 re-
perfusate; and 3) moderate depression of performance when pH
7.8 and hypocalcemia were combined.
cemie blood restarted more rap idly , fibrillated more vig-
orously and con sumed more oxygen dur ing the 5 minute
repcrfusion interval than did hearts receiving either unmod-
ified , hypocalcemic or alkalotic reperfusate alone . However ,
in contrast to our expectations, they functioned as poorl y
as those receiving unmodified reperfu sate (Fig . 2) . We sus-
pect the improved metabolic mil ieu of alkalotic pH allowed
ventricular fibrillation to be more active despite hypocal -
cem ia. Such fibrillation probably impeded subendoca rdial
blood supply when the repe rfusion pressure was low (80).
Cardioplegia. Our use of a blood cardioplegic reper-
fusate was based on our observation that the ischemically
damaged heart has a limited capacity to utilize oxygen dur-
ing reperfusion (7,8,40,41). This led to the hypothesis that
maintaining arrest during initial reperfusion would provide
conditions whereby a greater port ion of the oxygen delivered
on restoration of blood flow could be directed toward re-
parative pro cesses instead of needl ess electromechanical
work (such as fibrilla tion ). All repe rfused hearts (except
those recei ving blood cardioplegia) fibrillated and took up
only slightly more oxygen than needed to meet the basal
requ irements of ventricular fibrillation (Fig . 3). Con versely ,
hearts kept arre sted during reperfusion took up the same
total amount of oxygen, but con sumed 500% more oxygen
than needed to meet the low metabolic requirements of
arrest. We suspect this increased oxygen was used in part
to reestablish sodium-potass ium ATPase pumps as heart s
receiving cardioplegic reperfusion developed less post-
ischemic edema than those that fibrillated . The excess ox-
ygen uptake was also likel y used for the other forms of
reparative work that contributed to the improved postisch-
ernie complicance (81% recovery) in contractility (77% re-
covery) (13).
T
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Hyperosmolarity. Myocard ial edema can worsen re-
perfusion inju ry by increasing coro nary vasc ular resistance
and oxygen diffusion distance , alteri ng mitochondrial func-
tion and decreasing ventri cular compliance (37,81- 83). The
reperfusate was delivered at 40 to 50 mm Hg to avoid the
edema produced by high perfusion pressure (66). We mad e
the reperfusate hyperosmotic (360 mOsm) with hyperka-
lemia alone, as well as performing separate studies with
mann itol to distinguish the effects of cardioplegia from those
of hyperosmolarity. Both forms of hyperosmolarity produced
similar dehydrati on dur ing reperfusion, as well as compa-
rable recovery of postischemic perform ance when measured
30 minutes later (80 versus 76% +dP/dt) (65). The effec-
tiveness of mann itol may have been decreased by fibrillation
durin g reperfu sion which limited its distribution of mannit ol
to regional myocardial segments (80) and caused needless
expenditure of oxygen for electromechanical activity .
Hypocalcemia, alkalosis, cardioplegia and hyperos-
molarity. In recognizing the limitations of modifying only
one or two aspects of the repe rfusate , we reasoned that
combining all of them should provide maximal benefit. The
data recorded 30 minutes after reinstitut ing reperfu sion sup-
port this hypothesis; postischemi c left ventricular blood flow
and distribution were increased, left ventricular flow and
oxygen consumption augmented normally to meet increas-
ing metabolic demands , postischcmic water accumulation
Figure 3. Average myocardial oxygen uptake during reperfusion
after 60 minutes' topical hypothermic ischemic arrest. expressed
as percent of control requirements. Note: I ) slight augmentation
of oxygen uptake in fibrillating hearts receiving unmodified re-
perfusate (left); and 2) marked augmentation of postischemic ox-
ygen uptake during warm cardioplegic reperfusion (right) .
Low [Ca++]
pH 78
pH 7.8
Reperfusate
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75
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Figure 4. Postischemic myocardial performance during inscrip-
tion of left ventricular function curves 30 minutes after unclamping
the aorta. Note: 1) marked depression in function following 45
minutes of normothermic ischemia; and 2) normal function after
4 hours of multidose cold blood cardioplegia. LAP = left atrial
pressure; SWI = stroke work index.
sufficient aortic pressure or cardiac output to support the
systemic circulation. We then 1) contrasted the conse-
quences of the early use of intropic drugs to allow discon-
tinuation of bypass with those of temporary (30 minutes)
prolongation of extracorporeal circulation (7); 2) compared
the role of lowering oxygen demands with hypothermia (10)
during temporary bypass prolongation with that of a brief
continuous warm cardioplegic infusion to further decrease
oxygen demands (secondary cardioplegia) (8); and 3) eval-
uated the possible benefits of amino acid substrate replen-
ishment during reperfusion circulatory support (9, II).
Early inotropic support versus prolonging bypass
temporarily. Dopamine infusion (10 to 30 J,Lg/kg per min)
increased the cardiac output of failing hearts to normal levels
(Fig. 5) and allowed discontinuation of bypass with high
filling pressures. This pharmacologically induced increase
in contractility raised oxygen demands at a time when these
damaged hearts demonstrated a marked inability to utilize
delivered oxygen (only 17% oxygen extraction). Suben-
docardial flow did not increase to meet the demands of
increased cardiac work and the lactate production that char-
acterized these failing hearts before dopamine infusion be-
came accentuated (Fig. 6). Persistent and severe myocardial
damage was evident when final measurements were made
30 minutes later (no dopamine); myocardial edema was
pronounced (3.3% water gain), left ventricular compliance
was depressed (only 18% recovery, Fig. 7) and myocardial
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Reversal of Reperfusion Damage
Ischemic and reperfusion injury become apparent during
cardiac surgery only after extracorporeal circulation is dis-
continued. When severe myocardial damage prevents early
discontinuation of cardiopulmonary bypass, the therapeutic
options include either discontinuing bypass with pharma-
cologic (inotropic drugs) or mechanical support, or tem-
porary resumption of extracorporeal circulation to "rest"
the heart and improve the supply-demand balance. Most
surgeons have observed temporary resumption of extracor-
poreal circulation to result in some hemodynamic improve-
ment but rarely to allow complete recovery.
Experimentally, we simulated severe ischemic and re-
perfusion damage by subjecting dog hearts to 45 minutes
of normothermic aortic clamping and unmodified reperfu-
sion. Postischemic myocardial depression 15 minutes after
unclamping was so profound that no heart could generate
was minimal, compliance better and myocardial perfor-
mance was restored to preischemic levels (13).
Clinical implications. We concluded from these early
studies that the deleterious changes in myocardial metab-
olism, water content, compliance and performance after
temporary ischemia are caused in a large part by reperfusion
injury that can be avoided by appropriate reperfusate mod-
ification. Iftrue, this conclusion has significant clinical im-
plications, because the composition and pressure of reper-
fusate blood are under the control of the cardiac surgeon
and its possible manipulation may allow avoidance of the
damage that may occur if cardiac protection during aortic
clamping is less than ideal or if ischemic events precede
aortic clamping. On the basis of these studies, we use a
warm, low potassium (10 mEq/liter) blood cardioplegic
reperfusate routinely in clinical practice; cardiac activity
resumes regularly within 1 to 2 minutes after removing the
aortic clamp.
After completing these experiments, it became obvious
that the principles (such as cardioplegia, hypocalcemia, al-
kalosis and hyperosmolarity) underlying the composition of
the warm blood cardioplegic reperfusate used to avoid re-
perfusion damage were precisely those we had applied in
the past to prevent ischemic injury with asanguineous car-
dioplegia (18), differing only in the use of blood as the
vehicle for delivering oxygenated cardioplegia solution and
in solution temperature. These studies of reperfusion injury
therefore preceded and subsequently led to our experi-
mental and clinical use of cold blood cardioplegia as a
method of preventing myocardial damage (17). We have
shown that up to 4 hours of safe aortic clamping is possible
with cold blood cardioplegia (14) (Fig. 4) and we and others
use this method of myocardial protection to prevent ischemic
damage during aortic clamping in all operations for acquired
and congenital heart disease (17,50-52,85).
1240 J AM COLL CARDIOL
1983;1(5):1235-46
ROSENKRANZ AND BUCKBERG
performance was inadequate to support the circulation with-
out reinstitution of dopamine (Fig. 8).
In contrast, hearts treated with temporary prolongation
of bypass showed progressive metabolic and hemodynamic
Figure S. Myocardial performance 15 minutes after aortic un-
clamping following 45 minutes of nonnothennic arrest. Note: I)
cardiac output is profoundly depressed in all dogs after 45 mintues
of nonnothennic ischemic arrest (postischemia); and 2) cardiac
output is augmented with dopamine infusions, although higher left
atrial pressure (LAP) is needed and significant depression from
control is still present.
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improvement after oxygen demands were lowered by vent-
ing and ensuring myocardial perfusion pressure with extra-
corporeal circulation. Myocardial edema was mobilized, left
ventricular compliance improved, oxygen utilization in-
creased and bypass could be discontinued without inotropic
support (Fig. 8).
Figure 7. Left ventricular (LV) compliance 45 mintues after
ischemia (45 minutes of nonnothennic arrest). Note: I) marked
loss of compliance in hearts treated with dopamine; and 2) a greater
recovery of compliance in hearts treated with prolonged bypass.
LVEDP = left ventricular end-diastolic pressure.
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Figure 8. Left ventricular performance following 45 minutes of
nonnothennic ischemic arrest when I) dopamine was infused tem-
porarily (15 minutes), 2) bypass was prolonged for 30 mintues;
3) secondary cardioplegia was administered for 5 minutes during
prolonged bypass; and 4) glutamate was added to the secondary
cardioplegic solution. Note also the near normal recovery occurred
with substrate enhancement of secondary cardioplegic solution
with glutamate. Abbreviations as in Figure 4.
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Figure 6. Myocardial lactate metabolism after ischemia. Note: I)
postischemic working hearts produce lactate; and 2) lactate pro-
duction is accentuated during dopamine infusion.
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Figure 9. Myocardial oxygen uptake during reperfusion after isch-
emia (45 minutes' normothermic arrest), expressed as percent of
total requirements. Note: I) hearts allowed to beat with and without
hypothermia did not show postischemic augmentation of oxygen
uptake; and 2) hearts given warm (37°C) cardioplegia showed
expected augmentation of postischemic oxygen uptake.
blood cardioplegic infusion markedly exceeded basal de-
mands of normothermic arrest (Fig. 9). Postischemic hearts
allowedto beat duringhypothermiccoronary perfusionshowed
no more improvement of functional recovery than that
achieved with prolonging normothermic bypass (35 versus
37%) (8,10). These hearts maintained a persistent inability
to augment oxygen uptake when cardiac work was in-
creased. In contrast, maintaining normothermia while low-
ering oxygen demands with cardioplegia resulted in a better
ability to increase oxygen uptake (85 versus 40%) to meet
the increased demands of the working state and the gen-
eration of 50% greater stroke work than either hypothermia
or normothermic prolonged bypass (Fig. 8) (8).
These findings suggest that reducing postischemic oxygen
demands with hypothermia fails to improve recovery be-
cause it slows the rate of metabolic processes responsible
for repair. In contrast, reperfusion with secondary cardio-
plegia appears to be an effective method to channel the
limited capacity for oxygen utilization of damaged myo-
cardium toward reparative processes rather than obligating
it to be expended needlessly for electromechanical work.
The reversal of reperfusion damage was not complete, how-
ever, as oxygen extraction remained limited and left ven-
tricular function recovered to only 47% of control. Prolon-
gation of the interval of secondary cardioplegia to 10 minutes
provided no additional benefit (8). These observations di-
rected us to study the possibility that substrate replenishment
of the cardioplegic solution might reverse the defective ox-
idative metabolic processes that we felt were important for
recovery from ischemic and reperfusion injury.
Reperfusion amino acid substrate replenishment. We
selected L-glutamate as the test amino acid for substrate
replenishment of our blood cardioplegic reperfusate solution
because it can be converted to a-keto glutarate, a Krebs
cycle intermediate. Furthermore, it is lost from the myo-
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The detrimental effects of increasing energy demands
with inotropic drugs in ischemically damaged hearts are
well recognized (86-88). Our findings do not impugn the
usefulness of inotropic drugs postoperatively, but suggest
they should be used after the benefits of temporary prolon-
gation of bypass are expended. This study did not, however,
simulate the clinical conditions in which cardioplegia is used
and incomplete washout of the cardioplegic solution can
cause myocardial depression that is reversible by a single
calcium injection (500 mg calcium chloride intravenously).
Persistent myocardial depression after calcium injection,
however, suggests ischemic and reperfusion damage is pres-
ent and should be treated by briefly prolonging extracor-
poreal circulation.
Myocardial recovery remained incomplete (only 35% of
control values) despite the beneficial effects of prolonging
bypass. Our consistent findings of high coronary blood flow,
narrow coronary arteriovenous oxygen difference, post-
ischemic oxygen uptake that barely approaches the basal
needs of the beating state (instead of the postischemic aug-
mentation of oxygen uptake seen after reversible ischemia)
(8,89) and failure to increase oxygen uptake during cardiac
work led us to test the effects of lowering oxygen demands
further with either hypothermia or a brief warm cardioplegic
reperfusion during temporary prolonged bypass.
Reperfusion hypothermia versus secondary cardio-
plegia. Hypothermia is used routinely during ischemia to
minimize damage through delay of ATP depletion and slow-
ing of metabolic rate. During reperfusion, however, it is
our hypothesis that 1) the temperature-dependent processes
responsible for repair should be optimized by normothermia
rather than retarded by hypothermia (10); 2) any electro-
mechanical work of the bypassed heart is unneccessary and
may needlessly expend the limited oxygen utilization ca-
pacity during reperfusion (4); and 3) a warm brief continuous
cardioplegic infusion would allow this limited oxygen uti-
lization capacity to be used to repair cellular processes (8).
The decision to prolong bypass temporarily for 15 to 30
minutes in clinical practice provides the cardiac surgeon
with an obligatory and seemingly interminable interval of
inactivity. We simulated the condition of severe ischemic
and reperfusion damage (45 minutes' normothermic arrest
plus 15 minutes' unmodified reperfusion) in which the sur-
geon decided to prolong bypass for 30 minutes. We then
either reduced oxygen demands with an 18°C(pH 7.8) blood
infusion for 10 minutes or clamped the aorta and rearrested
the heart by delivering a 5 minute continuous infusion of
37°C blood cardioplegic solution (secondary cardioplegia)
(8).
Hypothermia decreased demands by lowering heart rate,
but was associated with a parallel reduction in myocardial
oxygen uptake (MV02) so that oxygen uptake remained
below the basal requirements of the beating empty state at
18°C. Conversely, myocardial oxygen uptake during 37°C
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Figure 10. Transmural left ventricular adenosine triphosphate (ATP)
content 15 minutes after ischemia (45 minutes of normothermic
arrest). Note that L-glutamate-treated hearts showed the greatest
ATP recovery.
cardium during ischemia (25,26) and is taken up more in
patients with ischemic heart disease than in patients with
normal coronary arteries (24). Monosodium glutamate is a
natural food substance that is used routinely during clinical
hyperalimentation in amounts far less than the 26 roM dose
used in our studies. It is, however, only one of several
amino acids (such as aspartate, arginine and ornithine) that
can be transformed to Krebs cycle intermediates involved
in substrate-level phosphorylation during oxidative metab-
olism (27,29,33).
Our pilot observations showing glutamate alone to result
in near complete return of oxidative metabolism and me-
chanical function after mild ischemic injury (9) (15 minutes'
normothermic ischemia) prompted us to test it with the more
severe ischemic insult of 45 minutes of global ischemia
followed by unmodified reperfusion. We added L-glutamate
to the secondary cardioplegic solution rather than testing it
separately because we believe that reversal of severe isch-
emic and reperfusion damage requires simultaneous atten-
tion to several aspects of the supply-demand balance. Glu-
tamate acts principally by enhancing substrate supply, but
we suspect that its action may be limited unless the acidosis
of ischemia is corrected (3,62,90), myocardial temperature
is optimal for continued metabolism, calcium influx limited
and energy demands reduced by cardioplegia (13).
The salutary effects of reperfusion with glutamate car-
dioplegia were apparent metabolically from the enhanced
oxygen uptake and ATP repletion occurring during its in-
fusion (Fig. 10). These benefits persisted 30 minutes later
when extracorporeal circulation was discontinued and myo-
cardial oxygen uptake increased more normally to meet
metabolic needs while cardiac performance returned to 80%
of control values (Fig. 8) (11).
We interpret these findings to mean that reversal of re-
perfusion damage is possible by replenishment of a pre-
cursor of a Krebs cycle intermediate lost during ischemia.
We reasoned, therefore, that glutamate inclusion in our stan-
dard blood cardioplegia may prevent this loss and allow a
longer safe interval of aortic clamping. Our recent studies
show that blood cardioplegia with and without glutamate
permitted up to 4 hours of safe aortic clamping in normal
hearts that were not subjected to preceding intervals of isch-
emia or reperfusion (14). These studies were carried out,
however, under the ideal circumstances of normal hearts
with good energy reserves and where optimal distribution
of cardioplegic solution was ensured by patent coronary
arteries. Such ideal conditions are clinically uncommon where
there is coronary disease or left ventricular hypertrophy and
where both factors may limit the effective distribution of
cardioplegic solution and decrease the tolerance to standard
ischemic insults (53,91,92).
Combining Avoidance of Reperjusion Damage With
Prevention of Ischemic Damage
Warm blood cardioplegic induction. Our improved
understanding of the role of warm blood cardioplegia in
avoiding and reversing reperfusion damage and that of cold
blood cardioplegia in preventing ischemic injury allowed us
to design a study to focus on a subset of patients whose
hearts are less tolerant to the prolonged periods of aortic
clamping needed for surgical repair because of preischemic
ATP depletion (54-56,58). Cold cardioplegia is used rou-
tinely in such patients (New York Heart Association class
IV, cardiogenic shock) but a significant risk of operative
damage still exists (93,94). Cardioplegic induction is, in
reality, the first phase of reperfusion when blood is the
cardioplegic vehicle. We reasoned that blood cardioplegia
is the ideal protective agent for these hearts because it has
the potential of serving the dual purpose of avoiding re-
perfusion damage when given warm and preventing further
energy depletion when given cold. We tested the hypothesis
that warm induction of blood cardioplegia would optimize
the rate of repair in energy-depleted hearts and improve
their tolerance to a subsequent prolonged period (2 hours)
of aortic clamping.
Our model for severe preischemic energy depletion was
45 minutes of normothermic global ischemia. This ischemic
insult reduced subendocardial ATP by 80%, a level previ-
ously thought to be incompatible with functional recovery
(44). These hearts were then either subjected to 2 additional
hours of aortic clamping with multidose cold blood cardio-
plegia (to simulate the time needed for complex surgical
repair) or given unmodified reperfusate without an added
ischemic period (79). With the cardioplegic delivery system
we use clinically (Fig. 11) (19), we compared the effects
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Figure 11. Cardioplegia delivery system in current clinical use.
Using a blood to cardioplegic tubing ratio of 4 to 1, blood from
the oxygenatoris mixedwithcardioplegic solution,passedthrough
a disposable heat exchanger (Shiley, USA) and infused into the
aortic root. The temperature of the heat exchanger is regulated by
the heater-cooler.
of a 5 minute period of 37°C cardioplegic induction followed
by standard multidose cold blood cardioplegia to cold car-
dioplegic induction with a similar cardioplegic regimen for
the following 2 hours of aortic clamping.
Hearts given unmodified reperfusate after 45 minutes of
ischemia (simulating resuscitation after cardiac arrest with-
out a subsequent ischemic period for cardiac repair) required
multiple defibrillations, showed the characteristic depres-
sion in postischemic oxygen utilization (Fig . 12) and had
markedly depressed ventricular performance (Fig. 13). In
contrast. all hearts given blood cardioplegia as the initial
reperfusate resumed beating spontaneously and consumed
oxygen in excess of basal requirement during the infusion;
the highest levels occurring with warm cardioplegic induc-
tion (13 versus 7 cell 00 g per min) . Energy depleted hearts
treated with cold induction recovered 63% of left ventricular
performance after 2 hours of aortic clamping compared with
95% recovery after 4 hours of aortic clamping when cold
blood cardioplegia was used in hearts with normal preis-
chemic energy levels (14,16). This "limitation" of multi-
dose cold blood cardioplegia in energy-depleted hearts was
overcome by preceding it with a 5 minute period of warm
cardioplegia; 85% recovery of left ventricular performance
occurred (Fig. 13) (16).
Glutamate enrichment of blood cardioplegic solu-
tion. We have recently continued our studies of glutamate
enrichment of blood cardioplegic solution by using both
warm and cold L-glutamate blood cardioplegic induction in
energy-depleted hearts subjected to an additional 2 hours of
multidose cold blood cardioplegic aortic clamping. Gluta-
mate enrichment of the cold blood cardioplegic solution did
not increase oxygen utliization during cardioplegic induc-
tion, but allowed recovery comparable with that seen with
**T
*T
Beating
Cardioplegia
* P< 0.05 vs 45 min Ischemia
** P< 0.05 vs Cold Induction
5
15
-5
10
-10
NET O2
kc/100gm)
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warm cardioplegic induction without glutamate (87% versus
85%) (96) . Glutamate enrichment of the warm blood car-
dioplegic solution produced the greatest oxygen uptake dur-
ing the period of cardioplegic induction and resulted in the
highest functional recovery (94%) of all hearts tested.
We think L-glutamate may play an important role in
anaerobic substrate level phosphorylation during aortic
clamping, as well as replenishing the Krebs cycle inter-
mediates lost during ischemia. Such replenishment allows
better aerobic metabolism when oxygen is restored during
reperfusion. We believe further study of glutamate and other
amino acid cardioplegic supplements is required and suggest
that amino acid supplementation of cardioplegic solutions
will become a vital component of future efforts at intra-
operative myocardial protection.
Clinical application. In clinical practice, we use this
method of warm cardioplegic induction in high risk patients
by varying the temperature of the heat exchanger as in these
experiments (Fig. 11) (79). We find that prompt arrest can
be induced with a warm cardioplegic solution by keeping
potassium concentration at 25 mEq/liter during the 5 minute
infusion and reducing the concentration to 10 mEq/liter
during the subsequent 5 minutes of cold cardioplegic in-
fusion and during replenishment at 20 minute intervals. This
relatively long period of cardioplegic induction is not det-
rimental: 1) the heart is perfused continually with oxygen-
ated blood while in a state of decreased metabolic demands;
2) the longer period of cold cardioplegia allows for better
Figure 12. Oxygen uptake in excess of basal requirements after
ischemia. Net O2 refers to oxygen consumed minus oxygen re-
quirements for metabolic state. Note: I) oxygen consumption be-
low requirements in hearts allowed to beat on reperfusion; 2)
oxygenconsumption in excessof requirements duringcardioplegic
reperfusion; and 3) highest oxygen uptake with warm induction.
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Figure 13. Left ventricular performance 30 minutes after blood
reperfusion. Note: I) normal postischemicperformance with warm
(37°C) cardioplegic induction; 2) moderate depression with cold
(4°C) cardioplegic induction; and 3) severe depression after nor-
mothermic ischemia with unmodified reperfusion. LAP = left
atrial pressure; SWI = stroke work index.
Conclusions
We conclude from these studies of myocardial protection
during surgical reperfusion that the surgeon can play an
active role in preventing, avoiding and reversing reperfusion
damage because he is in control of the temperature and
composition of reperfusate blood. The safety and simplicity
of current cardioplegic techniques suggest they will find
increasing usefulness during surgical revascularization of
patients with acute and extending myocardial infarctions.
The salutary effects of reperfusate modification provided by
our studies also suggest that control of reperfusate com-
myocardial cooling, especially beyond coronary stenoses
(15,91,92); 3) proximal or distal grafts or aortic valve re-
moval can be carried out while the cardioplegic solution is
being given; and 4) metabolic recovery is occurring during
this period of induction (16). Our experimental findings
were confirmed in a recent clinical report by Cunningham
(96) showing as much as 35% augmentation of subendo-
cardial ATP during warm blood cardioplegic induction in
patients with advanced valvular disease undergoing exten-
sive surgical repair with prolonged aortic clamping. Hope-
fully, further application of this technique will permit safer,
prolonged aortic clamping in patients who are still consid-
ered to be in the high risk category.
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